Erasca, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ARVN
|
Arvinas, Inc. | $25.74 | $1.83 B | -4.41 | 445 | $78.50 M |
 BDTX
|
Black Diamond Therapeutics, Inc. | $2.51 | $291.95 M | -3.13 | 54 | $0 |
 CCCC
|
C4 Therapeutics, Inc. | $4.23 | $320.64 M | -1.97 | 145 | $20.76 M |
 CGEM
|
Cullinan Oncology, Inc. | $12.23 | $1.29 B | -7.16 | 85 | $0 |
 DSGN
|
Design Therapeutics, Inc. | $5.67 | $217.51 M | -3.7 | 54 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $32.24 | $1.65 B | -11.47 | 108 | $0 |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $8.47 | $243.38 M | -1.59 | 133 | $0 |
 GRCL
|
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 |
 IPSC
|
Century Therapeutics, Inc. | $1.21 | $244.54 M | -1.32 | 152 | $2.24 M |
 KROS
|
Keros Therapeutics, Inc. | $55.00 | $1.76 B | -9.45 | 160 | $151,000 |
 LIFE
|
aTyr Pharma, Inc. | $1.90 | $131.12 M | -2.16 | 56 | $353,000 |
 MLYS
|
Mineralys Therapeutics, Inc. | $12.00 | $652.38 M | -6.03 | 28 | $0 |
 NGM
|
NGM Biopharmaceuticals, Inc. | $1.54 | $128.53 M | -0.89 | 138 | $4.42 M |
 OLMA
|
Olema Pharmaceuticals, Inc. | $8.58 | $734.41 M | -6.56 | 74 | $0 |
 PLRX
|
Pliant Therapeutics, Inc. | $13.00 | $672.63 M | -3.9 | 166 | $1.58 M |
 RLAY
|
Relay Therapeutics, Inc. | $4.71 | $1.05 B | -3 | 294 | $25.55 M |
 SANA
|
Sana Biotechnology, Inc. | $2.62 | $1.55 B | -4.59 | 328 | $0 |
 STOK
|
Stoke Therapeutics, Inc. | $11.27 | $774.50 M | -6.14 | 110 | $8.78 M |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |
 ZNTL
|
Zentalis Pharmaceuticals, Inc. | $3.29 | $754.16 M | -3.26 | 124 | $0 |